Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Public biotechnology 2005--the numbers.

Riku Lähteenmäki, Stacy Lawrence

    Nature Biotechnology
    |June 10, 2006
    PubMed
    Summary
    This summary is machine-generated.

    In 2005, despite investor caution, the biotechnology sector saw increased merger and acquisition (M&A) activity and collaborative research ventures. This indicates a growing trend in strategic partnerships within the industry.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Public biotech in 2022 - the numbers.

    Nature biotechnology·2023
    Same author

    Public biotech in 2021 - the numbers.

    Nature biotechnology·2022
    Same author

    Public biotech 2018-the numbers.

    Nature biotechnology·2019
    Same author

    Public biotech in 2017-the numbers.

    Nature biotechnology·2018
    Same author

    Public biotech in 2016-the numbers.

    Nature biotechnology·2017
    Same author

    Biotech's wellspring-a survey of the health of the private sector in 2016.

    Nature biotechnology·2017

    Area of Science:

    • Biotechnology
    • Business and Finance

    Background:

    • Investor sentiment towards public biotechnology companies was cautious in 2005.
    • Despite caution, underlying industry activity showed positive trends.

    Purpose of the Study:

    • To analyze trends in mergers, acquisitions, and research partnerships in the biotechnology sector.
    • To assess the relationship between investor caution and industry deal-making.

    Main Methods:

    • Analysis of publicly available data on biotechnology company transactions.
    • Review of financial reports and industry news from 2005.

    Main Results:

    • Mergers and acquisitions within the biotechnology sector showed an upward trend.
    • The number of research partnerships also increased significantly.

    Related Experiment Videos

    Conclusions:

    • The biotechnology industry experienced growth in strategic collaborations and M&A activity in 2005.
    • Positive deal-making trends suggest underlying industry strength despite cautious investor outlook.